Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$596.92 USD

596.92
2,138,161

+3.13 (0.53%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Here's Why You Should Retain Haemonetics (HAE) Stocks for Now

Investors are optimistic about Haemonetics (HAE) on a strong recovery across businesses, mainly at Hospital, and the initial Plasma Persona rollouts.

Medtronic's (MDT) INVOS System Gets FDA 510 (k) Clearance

Medtronic's (MDT) INVOS 7100 system can deliver key signals to pediatric clinicians for making time-sensitive decisions

Avantor (AVTR) to Improve Biopharma Supply Chain With New Site

Avantor's (AVTR) new logistics hub in Westminster is intended to support growth of single-use businesses.

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Thermo Fisher Scientific, Salesforce, Nike and Texas Instruments

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Thermo Fisher Scientific, Salesforce, Nike and Texas Instruments

Here's Why You Should Retain Catalent (CTLT) Stock for Now

Investors continue to be optimistic about Catalent (CTLT) owing to its robust facility expansion activities and a slew of strategic deals.

Mark Vickery headshot

Top Research Reports for Berkshire Hathaway, Thermo Fisher & salesforce

Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Thermo Fisher Scientific Inc. (TMO), and salesforce.com, inc. (CRM).

Here's Why You Should Hold on to NEOGEN (NEOG) Stock for Now

Investors are optimistic about NEOGEN (NEOG) given robust sales growth in the Food Safety business and impressive international performance.

Here's Why You Should Retain STERIS (STE) Stock for Now

Investors are optimistic about STERIS (STE) owing to strong segmental growth and bullish 2022 outlook.

Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know

In the latest trading session, Thermo Fisher Scientific (TMO) closed at $661.25, marking a +0.84% move from the previous day.

FDA Approves Intuitive Surgical's (ISRG) Latest SureForm Stapler

Intuitive Surgical's (ISRG) newest stapler is expected to result in better surgical outcomes.

NEOGEN (NEOG) Gains on 3M's Food Safety Arm Merger Deal

According to NEOGEN (NEOG), apart from the United States and Europe, substantial interest among developing nations to improve food safety presents significant growth potential for the combined company.

Walgreens (WBA), Village MD Plan to Expand Into San Antonio

Walgreens (WBA) and VillageMD to improve access to overall care for patients with chronic conditions by opening nine new Village Medical at Walgreens primary care practices in San Antonio.

Zacks Industry Outlook Highlights: Thermo Fisher Scientific, STERIS and Accuray

Zacks Industry Outlook Highlights: Thermo Fisher Scientific, STERIS and Accuray

Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now?

Smart Beta ETF report for FLQL

Veeva's (VEEV) Data Cloud to Aid PharmaEssentia's New Product

Adoption of Veeva Systems' (VEEV) cloud applications is likely to significantly boost its Commercial Cloud business.

Urmimala Biswas headshot

3 Top Medical Instruments Stocks to Counter Industry Headwinds

The Zacks Medical - Instruments industry is growing on COVID-support business gains. TMO, STE and ARAY are set to gain the most. Yet, demand for base business is on the decline with the new COVID variant disrupting the trend.

Illumina (ILMN) to Develop Synthetic Genomic Data With New Pact

Illumina's (ILMN) recent collaboration will allow it to leverage the best-quality synthetic data to remove privacy bottlenecks and accelerate the development of precision medicine.

Here's Why You Should Retain Charles River (CRL) Stock for Now

Investors are optimistic about Charles River (CRL) on acquisitions of Cognate BioServices and Vigene Biosciences.

Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?

Style Box ETF report for FLQL

Here's Why You Should Retain Veeva Systems (VEEV) Stock for Now

Investors continue to be optimistic about Veeva Systems (VEEV) owing to its strong product portfolio.

Study Favors Masimo's (MASI) SedLine for Better Patient Outcome

Masimo's (MASI) SedLine is expected to aid in the early identification of patients who are at risk of developing POD.

Here's Why You Should Retain Ecolab (ECL) Stock Right Now

Ecolab (ECL) continues to gain traction from a solid product portfolio and segmental strength. However, segmental weakness remains a woe.

Veeva Systems' (VEEV) Buyout to Bolster Clinical Offering

Veeva Systems' (VEEV) Veracity Logic buyout can help companies to simplify complex processes and speed up clinical trials.

CVS Health (CVS) Outlines Growth Strategy, Initiates 2022 View

CVS Health's (CVS) new strategy capitalizes on the considerable opportunity to make health care more convenient, personalized and affordable for consumers.

McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.